Living with ME/CFS, I endure a daily battle against fatigue, cognitive challenges, and a host of other debilitating symptoms. The condition’s impact on my life is profound, turning everyday tasks into monumental challenges. Despite these struggles, the available treatment options remain limited, with 'pacing' being the primary approach recommended to manage symptoms. While pacing can indeed help in managing energy expenditure, it doesn’t address the full spectrum of symptoms for many sufferers like myself.

An area that I believe holds significant promise for the ME/CFS community is the potential use of neurostimulants in treatment. Currently, there is minimal research into how these drugs, which are already employed in managing ADHD, might benefit individuals with ME/CFS. Neurostimulants are known to aid in improving alertness, attention, and executive functions such as memory, which are areas severely affected by ME/CFS. I believe that a combined therapy would hold promising results of potentially getting people back into work even if it's just part time hours.  

Advocating for well-structured, rigorous research into the use of neurostimulants for ME/CFS could unveil new, supplementary treatment pathways that complement existing strategies like pacing. By exploring this avenue, we could enhance the quality of life for many who suffer from this condition. It’s important to note that this approach would involve careful monitoring and consultation with medical professionals to ensure patient safety and tailor treatments to individual needs.

The necessity of expanding our understanding and options for ME/CFS is clear. Approximately 390,000 to 404,000 people in the UK have ME/CFS, though some estimates including those with ME-like symptoms from Long Covid could raise the total to over 1.3 million. A number that underscores the urgent need for diverse therapeutic strategies. Further study into neurostimulants could potentially help many of these individuals who remain underserved by current treatments, especially those experiencing profound cognitive difficulties and unrelenting fatigue. 

By signing this petition, you are supporting a call for increased funding and research into the application of neurostimulants as a viable treatment option. Let’s join together to push for advancements that could change lives and offer hope to those affected by ME/CFS. Please sign and share this petition to help us reach those who can prioritize this critical research.